全文获取类型
收费全文 | 1899068篇 |
免费 | 145769篇 |
国内免费 | 17286篇 |
专业分类
耳鼻咽喉 | 23750篇 |
儿科学 | 58220篇 |
妇产科学 | 50437篇 |
基础医学 | 264933篇 |
口腔科学 | 52480篇 |
临床医学 | 178271篇 |
内科学 | 364008篇 |
皮肤病学 | 41091篇 |
神经病学 | 142293篇 |
特种医学 | 71668篇 |
外国民族医学 | 338篇 |
外科学 | 280002篇 |
综合类 | 71670篇 |
现状与发展 | 52篇 |
一般理论 | 574篇 |
预防医学 | 136683篇 |
眼科学 | 46182篇 |
药学 | 145605篇 |
164篇 | |
中国医学 | 15026篇 |
肿瘤学 | 118676篇 |
出版年
2021年 | 20784篇 |
2020年 | 16138篇 |
2019年 | 20779篇 |
2018年 | 27528篇 |
2017年 | 21870篇 |
2016年 | 22947篇 |
2015年 | 28592篇 |
2014年 | 38304篇 |
2013年 | 49190篇 |
2012年 | 69321篇 |
2011年 | 73698篇 |
2010年 | 43935篇 |
2009年 | 39577篇 |
2008年 | 63465篇 |
2007年 | 66840篇 |
2006年 | 66810篇 |
2005年 | 64298篇 |
2004年 | 58703篇 |
2003年 | 55128篇 |
2002年 | 52367篇 |
2001年 | 96153篇 |
2000年 | 98084篇 |
1999年 | 81849篇 |
1998年 | 22071篇 |
1997年 | 19630篇 |
1996年 | 18943篇 |
1995年 | 19058篇 |
1994年 | 17309篇 |
1993年 | 15402篇 |
1992年 | 58991篇 |
1991年 | 56762篇 |
1990年 | 54196篇 |
1989年 | 51810篇 |
1988年 | 47044篇 |
1987年 | 45767篇 |
1986年 | 42858篇 |
1985年 | 40506篇 |
1984年 | 29641篇 |
1983年 | 25113篇 |
1982年 | 13998篇 |
1979年 | 25621篇 |
1978年 | 17615篇 |
1977年 | 14916篇 |
1976年 | 13894篇 |
1975年 | 14566篇 |
1974年 | 17673篇 |
1973年 | 16968篇 |
1972年 | 15712篇 |
1971年 | 14488篇 |
1970年 | 13464篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
3.
宫腔积液指宫腔内液体积存(积水、积血或积脓),是绝经后女性常见体征之一,常于超声检查时发现。持续宫腔积液患者,需宫腔镜检查寻找病因。本文报道1例以宫腔积液为首发症状,经宫腔镜检查确诊为胃型宫颈腺癌的患者。通过病例回顾并文献复习,以期为更多绝经后宫腔积液及宫颈病变的诊断提供参考,避免漏诊及误诊。1病例资料患者67岁,女,主因"绝经18年,不规则阴道出血2月"于2020年5月就诊于首都医科大学附属北京妇产医院妇科微创中心。 相似文献
4.
5.
Maja Popovic Gorana Matovina-Brko Masa Jovic Lazar S Popovic 《World journal of clinical oncology》2022,13(1):28-38
Renal cell cancer (RCC) represents 2%-3% of all adulthood cancers and is the most common malignant neoplasm of the kidney (90%). In the mid-nineties of the last century, the standard of treatment for patients with metastatic RCC was cytokines. Sunititib and pazopanib were registered in 2007 and 2009, respectively, and have since been the standard first-line treatment for metastatic clear cell RCC (mccRCC). Renal cell cancer is a highly immunogenic tumor with tumor infiltrating cells, including CD8+ T lymphocytes, dendritic cells, natural killer cells (NK) and macrophages. This observation led to the design of new clinical trials in which patients were treated with immunotherapy. With the growing evidence that proangiogenic factors can have immunomodulatory effects on the host’s immune system, the idea of combining angiogenic drugs with immunotherapy has emerged, and new clinical trials have been designed. In the last few years, several therapeutic options have been approved [immunotherapy and immunotherapy/tyrosine kinase inhibitors (TKI)] for the first-line treatment of mccRCC. Nivolumab/ipilimumab is approved for the treatment of patients with inter mediate and poor prognoses. Several checkpoint inhibitors (pembrolizumab, nivolumab, avelumab) in combination with TKI (axitinib, lenvatinib, cabozan tinib) are approved for the treatment of patients regardless of their International mRCC Database Consortium prognostic group and PD-L1 expression. There is no specific and ideal biomarker that could help in selecting the ideal patient for the appropriate first-line treatment. 相似文献
6.
Rozhkov V. P. Trifonov M. I. Soroko S. I. 《Neuroscience and behavioral physiology》2022,52(3):383-394
Neuroscience and Behavioral Physiology - We present here results from analysis of the formation of brain bioelectrical activity in children and adolescents living in the northern region of Russia... 相似文献
7.
8.
9.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
10.